RPRX logo

Royalty Pharma plc (RPRX) Operating profit

annual operating profit:

$1.29B-$199.71M(-13.38%)
December 31, 2024

Summary

  • As of today (September 11, 2025), RPRX annual operating income is $1.29 billion, with the most recent change of -$199.71 million (-13.38%) on December 31, 2024.
  • During the last 3 years, RPRX annual operating profit has fallen by -$138.27 million (-9.66%).
  • RPRX annual operating profit is now -50.73% below its all-time high of $2.62 billion, reached on December 31, 2019.

Performance

RPRX Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

quarterly operating profit:

$209.80M-$324.38M(-60.73%)
June 30, 2025

Summary

  • As of today (September 11, 2025), RPRX quarterly operating income is $209.80 million, with the most recent change of -$324.38 million (-60.73%) on June 30, 2025.
  • Over the past year, RPRX quarterly operating profit has dropped by -$59.83 million (-22.19%).
  • RPRX quarterly operating profit is now -84.25% below its all-time high of $1.33 billion, reached on December 31, 2019.

Performance

RPRX quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

TTM operating profit:

$1.84B-$59.83M(-3.15%)
June 30, 2025

Summary

  • As of today (September 11, 2025), RPRX TTM operating income is $1.84 billion, with the most recent change of -$59.83 million (-3.15%) on June 30, 2025.
  • Over the past year, RPRX TTM operating profit has increased by +$880.38 million (+91.69%).
  • RPRX TTM operating profit is now -30.15% below its all-time high of $2.64 billion, reached on June 30, 2020.

Performance

RPRX TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

RPRX Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-13.4%-22.2%+91.7%
3 y3 years-9.7%-44.5%+74.6%
5 y5 years-50.7%-48.8%-30.1%

RPRX Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-13.4%+40.0%-71.5%+384.4%-3.1%+99.4%
5 y5-year-50.7%+40.0%-71.8%+384.4%-30.1%+99.4%
alltimeall time-50.7%+78.8%-84.3%+384.4%-30.1%+327.1%

RPRX Operating profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$209.80M(-60.7%)
$1.84B(-3.1%)
Mar 2025
-
$534.18M(+47.8%)
$1.90B(+47.0%)
Dec 2024
$1.29B(-13.4%)
$361.51M(-50.8%)
$1.29B(-16.3%)
Sep 2024
-
$735.07M(+172.6%)
$1.54B(+60.8%)
Jun 2024
-
$269.63M(-465.5%)
$960.19M(+2.2%)
Mar 2024
-
-$73.77M(-112.0%)
$939.40M(-37.0%)
Dec 2023
$1.49B(+61.7%)
$612.90M(+304.7%)
$1.49B(+47.4%)
Sep 2023
-
$151.44M(-39.1%)
$1.01B(-3.9%)
Jun 2023
-
$248.84M(-48.0%)
$1.05B(-10.9%)
Mar 2023
-
$478.97M(+259.7%)
$1.18B(+28.1%)
Dec 2022
$922.89M(-35.5%)
$133.17M(-30.7%)
$922.89M(-2.1%)
Sep 2022
-
$192.21M(-49.1%)
$943.14M(-10.5%)
Jun 2022
-
$377.79M(+71.9%)
$1.05B(-25.8%)
Mar 2022
-
$219.72M(+43.2%)
$1.42B(-0.7%)
Dec 2021
$1.43B
$153.42M(-49.4%)
$1.43B(-13.6%)
DateAnnualQuarterlyTTM
Sep 2021
-
$303.05M(-59.3%)
$1.66B(-11.1%)
Jun 2021
-
$744.95M(+224.9%)
$1.86B(+22.0%)
Mar 2021
-
$229.30M(-39.5%)
$1.53B(-8.0%)
Dec 2020
$1.60B(-39.2%)
$379.11M(-25.7%)
$1.66B(-36.5%)
Sep 2020
-
$510.57M(+24.7%)
$2.61B(-0.8%)
Jun 2020
-
$409.35M(+13.3%)
$2.64B(+3.2%)
Mar 2020
-
$361.43M(-72.9%)
$2.55B(-2.6%)
Dec 2019
$2.62B(+92.3%)
$1.33B(+150.1%)
$2.62B(+103.1%)
Sep 2019
-
$532.50M(+62.4%)
$1.29B(+70.2%)
Jun 2019
-
$327.86M(-23.9%)
$758.76M(+76.1%)
Mar 2019
-
$430.90M
$430.90M
Dec 2018
$1.36B(+45.2%)
-
-
Dec 2017
$939.69M(+30.0%)
-
-
Dec 2016
$722.87M(-9.0%)
-
-
Dec 2015
$794.28M
-
-

FAQ

  • What is Royalty Pharma plc annual operating income?
  • What is the all time high annual operating profit for Royalty Pharma plc?
  • What is Royalty Pharma plc annual operating profit year-on-year change?
  • What is Royalty Pharma plc quarterly operating income?
  • What is the all time high quarterly operating profit for Royalty Pharma plc?
  • What is Royalty Pharma plc quarterly operating profit year-on-year change?
  • What is Royalty Pharma plc TTM operating income?
  • What is the all time high TTM operating profit for Royalty Pharma plc?
  • What is Royalty Pharma plc TTM operating profit year-on-year change?

What is Royalty Pharma plc annual operating income?

The current annual operating profit of RPRX is $1.29B

What is the all time high annual operating profit for Royalty Pharma plc?

Royalty Pharma plc all-time high annual operating income is $2.62B

What is Royalty Pharma plc annual operating profit year-on-year change?

Over the past year, RPRX annual operating income has changed by -$199.71M (-13.38%)

What is Royalty Pharma plc quarterly operating income?

The current quarterly operating profit of RPRX is $209.80M

What is the all time high quarterly operating profit for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly operating income is $1.33B

What is Royalty Pharma plc quarterly operating profit year-on-year change?

Over the past year, RPRX quarterly operating income has changed by -$59.83M (-22.19%)

What is Royalty Pharma plc TTM operating income?

The current TTM operating profit of RPRX is $1.84B

What is the all time high TTM operating profit for Royalty Pharma plc?

Royalty Pharma plc all-time high TTM operating income is $2.64B

What is Royalty Pharma plc TTM operating profit year-on-year change?

Over the past year, RPRX TTM operating income has changed by +$880.38M (+91.69%)
On this page